A phase II study of durvalumab, doxorubicin, and ifosfamide in recurrent and/or metastatic pulmonary sarcomatoid carcinoma (KCSG LU-19-24).

  • Keam, Bhumsuk; 
  • Youk, Jeonghwan; 
  • Kim, Tae Min; 
  • Lee, Gyeong-Won; 
  • Kim, Dong-Wan; 
  • 외 1명
Citations

WEB OF SCIENCE

0
제목
A phase II study of durvalumab, doxorubicin, and ifosfamide in recurrent and/or metastatic pulmonary sarcomatoid carcinoma (KCSG LU-19-24).
저자
Keam, Bhumsuk; Youk, Jeonghwan; Kim, Tae Min; Lee, Gyeong-Won; Kim, Dong-Wan; Kim, Miso
DOI
10.1200/JCO.2025.43.16_suppl.8566
발행일
2025-06
유형
Meeting Abstract
저널명
Journal of Clinical Oncology
권
43
호
16_SUPPL